-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 24, the official website of the State Food and Drug Administration showed that five companies including Qilu Pharmaceutical, Dongguan Yangzhikang Pharmaceutical, and Hunan Jiudian Pharmaceutical were approved for listing on the same day as Rivaroxaban tablets.
May 24, 2021 release of drug approval documents pending information release
According to data, Rivaroxaban tablets were jointly developed by Bayer and Janssen Pharmaceuticals.
Sales of rivaroxaban tablets in Chinese public medical institutions and physical pharmacies in Chinese cities
Source: Mi Nei Net Database
According to data from Minai.
Prior to this, there were nearly 20 manufacturers of rivaroxaban tablets.
Source: official website of the State Food and Drug Administration, Mi Nei.